Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733808 | SCV000861908 | pathogenic | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001229793 | SCV001402250 | pathogenic | Cholestanol storage disease | 2021-11-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 597631). This variant is also known as p.Gln428*. This premature translational stop signal has been observed in individuals with Cerebrotendinous xanthomatosis (PMID: 11181744, 20925952). This variant is present in population databases (rs771819245, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Gln461*) in the CYP27A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP27A1 are known to be pathogenic (PMID: 9392430, 10775536, 26937392). |
Institute of Human Genetics, |
RCV001229793 | SCV002765063 | pathogenic | Cholestanol storage disease | 2022-11-22 | criteria provided, single submitter | clinical testing | _x000D_This variant was identified as compound heterozygous with NM_000784.4:c.1297dup Criteria applied: PVS1, PM3_STR, PM2_SUP |